
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery
Sponsor : Innovation Endeavors
Deal Size : $8.7 million
Deal Type : Financing
BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies
Details : The net proceeds will be used to advance company's proprietary platform technology and antibody degrader programs and to develop pre-clinical assets and form strategic partnerships with large pharma companies.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
September 19, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery
Sponsor : Innovation Endeavors
Deal Size : $8.7 million
Deal Type : Financing
